Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rapid Establishment of a Cold Chain Capacity of -60°C or Colder for the STRIVE Ebola Vaccine Trial During the Ebola Outbreak in Sierra Leone.

Literature DB >> 29788339

Rapid Establishment of a Cold Chain Capacity of -60°C or Colder for the STRIVE Ebola Vaccine Trial During the Ebola Outbreak in Sierra Leone.

Morrison O Jusu¹, Geoffrey Glauser², Jane F Seward³, Mohamed Bawoh¹, Judith Tempel⁴, Michael Friend⁵, Daniel Littlefield⁴, Michael Lahai¹, Hassan M Jalloh¹, Amara Bangali Sesay¹, Amanda F Caulker¹, Mohamed Samai¹, Vasavi Thomas³, Nicholas Farrell³, Marc-Alain Widdowson³.

Abstract

Clinical Trials Registration: ClinicalTrials.gov [NCT02378753] and Pan African Clinical Trials Registry [PACTR201502001037220].

Entities: Species

Mesh：

Substances：
Ebola Vaccines

Year: 2018 PMID： 29788339 PMCID： PMC6927859 DOI： 10.1093/infdis/jix336

Source DB: PubMed Journal: J Infect Dis ISSN： 0022-1899 Impact factor: 5.226

11 in total

1. Meeting of the Strategic Advisory Group of Experts on immunization, October 2015 – conclusions and recommendations.

Authors:
Journal: Wkly Epidemiol Rec Date: 2015-12-11

2. Ebola vaccine will be made available for emergency use.

Authors: Anne Gulland
Journal: BMJ Date: 2016-01-22

3. Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.

Authors: Selidji T Agnandji; Angela Huttner; Madeleine E Zinser; Patricia Njuguna; Christine Dahlke; José F Fernandes; Sabine Yerly; Julie-Anne Dayer; Verena Kraehling; Rahel Kasonta; Akim A Adegnika; Marcus Altfeld; Floriane Auderset; Emmanuel B Bache; Nadine Biedenkopf; Saskia Borregaard; Jessica S Brosnahan; Rebekah Burrow; Christophe Combescure; Jules Desmeules; Markus Eickmann; Sarah K Fehling; Axel Finckh; Ana Rita Goncalves; Martin P Grobusch; Jay Hooper; Alen Jambrecina; Anita L Kabwende; Gürkan Kaya; Domtila Kimani; Bertrand Lell; Barbara Lemaître; Ansgar W Lohse; Marguerite Massinga-Loembe; Alain Matthey; Benjamin Mordmüller; Anne Nolting; Caroline Ogwang; Michael Ramharter; Jonas Schmidt-Chanasit; Stefan Schmiedel; Peter Silvera; Felix R Stahl; Henry M Staines; Thomas Strecker; Hans C Stubbe; Benjamin Tsofa; Sherif Zaki; Patricia Fast; Vasee Moorthy; Laurent Kaiser; Sanjeev Krishna; Stephan Becker; Marie-Paule Kieny; Philip Bejon; Peter G Kremsner; Marylyn M Addo; Claire-Anne Siegrist
Journal: N Engl J Med Date: 2015-04-01 Impact factor: 91.245

4. Is the world ready for an Ebola vaccine?

Authors: Bruce Y Lee; William J Moss; Lois Privor-Dumm; Dagna O Constenla; Maria D Knoll; Katherine L O'Brien
Journal: Lancet Date: 2015-01-17 Impact factor: 79.321

5. The Ebola epidemic: a global health emergency.

Authors: Lawrence O Gostin; Daniel Lucey; Alexandra Phelan
Journal: JAMA Date: 2014-09-17 Impact factor: 56.272

6. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.

Authors: Ana Maria Henao-Restrepo; Ira M Longini; Matthias Egger; Natalie E Dean; W John Edmunds; Anton Camacho; Miles W Carroll; Moussa Doumbia; Bertrand Draguez; Sophie Duraffour; Godwin Enwere; Rebecca Grais; Stephan Gunther; Stefanie Hossmann; Mandy Kader Kondé; Souleymane Kone; Eeva Kuisma; Myron M Levine; Sema Mandal; Gunnstein Norheim; Ximena Riveros; Aboubacar Soumah; Sven Trelle; Andrea S Vicari; Conall H Watson; Sakoba Kéïta; Marie Paule Kieny; John-Arne Røttingen
Journal: Lancet Date: 2015-08-03 Impact factor: 79.321

7. Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges.

Authors: Stephen B Kennedy; James D Neaton; H Clifford Lane; Mark W S Kieh; Moses B F Massaquoi; Nancy A Touchette; Martha C Nason; Dean A Follmann; Fatorma K Boley; Melvin P Johnson; Gregg Larson; Francis N Kateh; Tolbert G Nyenswah
Journal: Clin Trials Date: 2016-01-14 Impact factor: 2.486

8. Implementing an Ebola Vaccine Study - Sierra Leone.

Authors: Marc-Alain Widdowson; Stephanie J Schrag; Rosalind J Carter; Wendy Carr; Jennifer Legardy-Williams; Laura Gibson; Durodami R Lisk; Mohamed I Jalloh; Donald A Bash-Taqi; Samuel A Sheku Kargbo; Ayesha Idriss; Gibrilla F Deen; James B W Russell; Wendi McDonald; Alison P Albert; Michelle Basket; Amy Callis; Victoria M Carter; Kelli R Clifton Ogunsanya; Julianne Gee; Robert Pinner; Barbara E Mahon; Susan T Goldstein; Jane F Seward; Mohamed Samai; Anne Schuchat
Journal: MMWR Suppl Date: 2016-07-08

9. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).

Authors: Ana Maria Henao-Restrepo; Anton Camacho; Ira M Longini; Conall H Watson; W John Edmunds; Matthias Egger; Miles W Carroll; Natalie E Dean; Ibrahima Diatta; Moussa Doumbia; Bertrand Draguez; Sophie Duraffour; Godwin Enwere; Rebecca Grais; Stephan Gunther; Pierre-Stéphane Gsell; Stefanie Hossmann; Sara Viksmoen Watle; Mandy Kader Kondé; Sakoba Kéïta; Souleymane Kone; Eewa Kuisma; Myron M Levine; Sema Mandal; Thomas Mauget; Gunnstein Norheim; Ximena Riveros; Aboubacar Soumah; Sven Trelle; Andrea S Vicari; John-Arne Røttingen; Marie-Paule Kieny
Journal: Lancet Date: 2016-12-23 Impact factor: 79.321

10. The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola.

Authors:
Journal: BMJ Date: 2015-07-27

9 in total

Review 1. mRNA vaccines for infectious diseases: principles, delivery and clinical translation.

Authors: Namit Chaudhary; Drew Weissman; Kathryn A Whitehead
Journal: Nat Rev Drug Discov Date: 2021-08-25 Impact factor: 112.288

2. Analysis and modeling of coolants and coolers for specimen transportation.

Authors: David E Lowe; Gerald Pellegrini; Elizabeth LeMasters; Andrew J Carter; Zachary P Weiner
Journal: PLoS One Date: 2020-04-17 Impact factor: 3.240

3. Disrupting vaccine logistics.

Authors: Eric R James
Journal: Int Health Date: 2021-04-27 Impact factor: 2.473

4. Mean kinetic temperature evaluations through simulated temperature excursions and risk assessment with oral dosage usage for health programs.

Authors: David Jenkins; Aida Cancel; Thomas Layloff
Journal: BMC Public Health Date: 2022-02-14 Impact factor: 3.295

Review 5. 'Learn from the lessons and don't forget them': identifying transferable lessons for COVID-19 from meningitis A, yellow fever and Ebola virus disease vaccination campaigns.

Authors: Julie Collins; Rosie Westerveld; Kate A Nelson; Hana Rohan; Hilary Bower; Siobhan Lazenby; Gloria Ikilezi; Rebecca Bartlein; Daniel G Bausch; David S Kennedy
Journal: BMJ Glob Health Date: 2021-09